Top Markets
Coin of the day
GSK plc GSK plc

GSK plc

GSK
株式のランク #9382
GSK plc is a global pharmaceutical and healthcare company, deeply involved in... GSK plc is a global pharmaceutical and healthcare company, deeply involved in the research, development, production, and commercialization of a diverse range of medicinal and wellness products. Its operations span the United Kingdom, the United States, and numerous other international markets. The company structures its operations across four primary divisions: Pharmaceuticals, Pharmaceutical R&D, Vaccines, and Consumer Healthcare. Within its Pharmaceuticals segment, GSK provides treatments addressing a wide array of therapeutic areas. These include respiratory conditions, HIV, immuno-inflammatory diseases, oncology, viral infections, central nervous system disorders, cardiovascular and urogenital health, metabolic imbalances, bacterial infections, and dermatological issues. The Consumer Healthcare division offers products across categories such as wellness, oral hygiene, nutritional supplements, and skin health. These consumer offerings come in a variety of formats, including oral dosage forms (e.g., tablets, syrups, lozenges, gummies, soft chews, effervescents), topical applications (e.g., gels, creams, patches, lip balms), nasal sprays, and a comprehensive range of oral hygiene products (e.g., toothpastes, mouthwashes, denture care items), alongside other specialized formulations like infant drops and wipes. GSK actively engages in various collaborative ventures. Its collaboration agreements include partnerships with 23andMe, Lyell Immunopharma, Inc., Novartis, Sanofi SA, Surface Oncology, Progentec Diagnostics, Inc., Alector, Inc., and CureVac AG. Additionally, the company maintains strategic alliances with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. Originally established in 1715, the company operated under the name GlaxoSmithKline plc until its rebranding to GSK plc in May 2022. Its corporate headquarters are situated in Brentford, United Kingdom.
株価
$25.28
最終同期: 2026-09-18
時価総額
$1.01B
変化(1日)
-2.29%
変化(1年)
-37.84%
GB
取引 GSK plc (GSK)

カテゴリー

GSK plc(GSK)の利益
Jun 2026 時点の利益 TTM: $8.03B
GSK plc の最新の財務報告によると、同社の現在の利益は $8.03B です。2024 年には $4.36B の利益を上げ、これは 2023 年の利益 $7.72B と 減少 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
GSK plc の利益の推移(2000 〜 2026)
各年末の利益
利益 変化
2026 (TTM) $8.03B -17.47%
2025 $9.73B 123.11%
2024 $4.36B -43.48%
2023 $7.72B 13.38%
2022 $6.81B 39.93%
2021 $4.87B -31.16%
2020 $7.07B -14.32%
2019 $8.25B 34.93%
2018 $6.11B 28.34%
2017 $4.76B 99.06%
2016 $2.39B -84.57%
2015 $15.51B 235.45%
2014 $4.62B -58.00%
2013 $11.01B 2.83%
2012 $10.71B -10.38%
2011 $11.95B 143.12%
2010 $4.91B -61.53%
2009 $12.77B 31.37%
2008 $9.72B -35.26%
2007 $15.02B -1.77%
2006 $15.29B 31.99%
2005 $11.58B 4.33%
2004 $11.10B -1.73%
2003 $11.30B 27.36%
2002 $8.87B 0.26%
2001 $8.85B -1.72%
2000 $9.00B 0.00%
同業他社の利益
企業 利益 利益の差
$33.59B 318.17%
US
$25.20B 213.63%
US
$8.70B 8.28%
US
$21.39B 166.24%
CH
$5.95B -25.96%
US